125 related articles for article (PubMed ID: 7518275)
1. Enhanced tenascin immunoreactivity in leukoplakia and squamous cell carcinoma of the oral cavity: an immunohistochemical study.
Shrestha P; Sakamoto F; Takagi H; Yamada T; Mori M
Eur J Cancer B Oral Oncol; 1994; 30B(2):132-7. PubMed ID: 7518275
[TBL] [Abstract][Full Text] [Related]
2. Intracellular localization of tenascin in squamous cell carcinoma of oral cavity: an immunohistochemical study.
Mori M; Muramatsu Y; Yamada K; Shrestha P; Takai Y
Anticancer Res; 1996; 16(5B):3075-9. PubMed ID: 8920770
[TBL] [Abstract][Full Text] [Related]
3. Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma.
Tiitta O; Happonen RP; Virtanen I; Luomanen M
J Oral Pathol Med; 1994 Nov; 23(10):446-50. PubMed ID: 7532219
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
5. Expression of tenascin in hamster buccal pouch mucosa during experimental carcinogenesis.
Lee SK; Park SC; Chi JG; Sakamoto F; Shrestha P; Mori M
Eur J Cancer B Oral Oncol; 1995 May; 31B(3):188-92. PubMed ID: 7549759
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential.
Harada T; Shinohara M; Nakamura S; Oka M
Virchows Arch; 1994; 424(3):257-66. PubMed ID: 7514477
[TBL] [Abstract][Full Text] [Related]
7. Tenascin expression in normal and abnormal human endometrium.
Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of Tenascin in embryogenesis, tumorigenesis and inflammatory oral mucosa.
Mane DR; Kale AD; Naik VV
Arch Oral Biol; 2011 Jul; 56(7):655-63. PubMed ID: 21208610
[TBL] [Abstract][Full Text] [Related]
9. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
[TBL] [Abstract][Full Text] [Related]
10. Tenascin expression in basal cell carcinoma.
Verstraeten AA; Mackie EJ; Hageman PC; Hilgers J; Schol DJ; De Jongh GJ; Schalkwijk J
Br J Dermatol; 1992 Dec; 127(6):571-4. PubMed ID: 1282358
[TBL] [Abstract][Full Text] [Related]
11. Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions.
Sunaga H; Fujieda S; Tsuzuki H; Asamoto K; Fukuda M; Saito H
Anticancer Res; 2001; 21(4B):2901-6. PubMed ID: 11712784
[TBL] [Abstract][Full Text] [Related]
12. Alterations in expression of basement membrane proteins during tumour progression in oral mucosa.
Kannan S; Balaram P; Chandran GJ; Pillai MR; Mathew B; Nalinakumari KR; Nair MK
Histopathology; 1994 Jun; 24(6):531-7. PubMed ID: 8063281
[TBL] [Abstract][Full Text] [Related]
13. Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach.
Tiitta O; Sipponen P; Gould V; Virtanen I
Virchows Arch; 1994; 425(4):369-74. PubMed ID: 7529617
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes.
Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sasaki O; Sugimachi K
Br J Cancer; 1995 Jul; 72(1):189-92. PubMed ID: 7541237
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining of tenascin in Warthin's tumor and in oncocytoma.
Sunardhi-Widyaputra S; Van Damme B
Oral Surg Oral Med Oral Pathol; 1993 Sep; 76(3):325-9. PubMed ID: 7690924
[TBL] [Abstract][Full Text] [Related]
16. Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma.
Häkkinen L; Kainulainen T; Salo T; Grenman R; Larjava H
Oral Dis; 1999 Jul; 5(3):210-7. PubMed ID: 10483066
[TBL] [Abstract][Full Text] [Related]
17. Valuation of exfoliative cytology as prediction factor in oral mucosa lesions.
Brunotto M; Zárate AM; Cismondi A; Fernández Mdel C; Noher de Halac RI
Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E92-102. PubMed ID: 15995578
[TBL] [Abstract][Full Text] [Related]
18. Tenascin in human neoplasia.
Shrestha P; Kusakabe M; Mori M
Int J Oncol; 1996 Apr; 8(4):741-55. PubMed ID: 21544422
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
20. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis.
Wallace WA; Howie SE; Lamb D; Salter DM
J Pathol; 1995 Apr; 175(4):415-20. PubMed ID: 7540684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
